What elements in the physician‐patient relationship (PPR) contribute to patient satisfaction: Development of a short form PPRS‐Patient Version (PPRS‐Patient SF) Questionnaire

Author(s):  
Douglas A. Drossman ◽  
Olafur Palsson ◽  
Ellen Stein ◽  
Johannah Ruddy ◽  
Anne Marie O'Broin Lennon
2020 ◽  
Author(s):  
Magdalena Romanowicz ◽  
Tyler Oesterle ◽  
Paul E. Croarkin ◽  
Bruce Sutor

Abstract IntroductionPatient satisfaction is defined as the perception that one’s general health care needs are being met. Prior research suggests that positive patient satisfaction with health care facilitates the physician-patient relationship and enhances the quality of life. Unfortunately, little is known about what factors play a role in influencing patient satisfaction. Objective The primary purpose of this study was to assess patient satisfaction (as measured by the PSQ-18 Patient Satisfaction Questionnaire) of patients seen by general psychiatry residents and to examine what factors might impact patient satisfaction. A secondary purpose was to explore the effects of (three one hour sessions) mentalization skills training on the physician-patient relationship and patient satisfaction. We hypothesized that depressive and anxiety symptoms would negatively impact patient satisfaction. We hypothesized that patients’ satisfaction scores would improve if care was provided by residents who completed mentalization training.MethodsThis was a prospective case-control study, enrolling adult patients (n = 157) referred for psychiatric assessment in a psychiatric resident outpatient clinic. The Short Form PSQ-18 for patients was the primary outcome variable and was compared to Patient Health Questionaire (PHQ-9) and anxiety Generalized Anxiety Disorder 7-Item scale (GAD-7) questionnaires. Outcome data from the PSQ-18 was compared among residents who either had or had not completed mentalization training. The data were analyzed with univariate analyses and to test multiple linear regression. ResultsOverall the patients were satisfied with clinician communication and interpersonal manner (PSQ-18 average scores of 4.21 +/- 0.66 and 4.15+/-0.69 respectively). The patients score on PHQ-9 was inversely related to their scores on time spent (TS) [p = 0.01] and accessibility/convenience (AC) [0.0009] subscale of patient satisfaction. GAD-7 score was inversely related to patients scores on AC subscale (p = 0.01). In regards to mentalization training, there was no difference in IRI (Interpersonal Reactivity Index) scores between the groups aside from Perspective taking (PT) subscale ( p = 0.029). Conclusions Our study reveals that depression and anxiety can negatively impact PSQ-18 patient scoring in psychiatric outpatients seen for the first time in a resident clinic. However, this study failed to show that a brief mentalization- based training could improve patient satisfaction scores that were already quite high at baseline.


Author(s):  
Sathorn Preechavuthinant ◽  
William Willis ◽  
Alberto Coustasse

Purpose The purpose of this paper is to investigate the current trend of pharmaceutical direct-to-consumer advertising (DTCA) in the USA and its effect to patients, physicians and drug utilization. The DTCA of pharmaceutical firms is defined as an attempt of pharmaceutical companies to advertise product directly to patients. Design/methodology/approach The methodology used is literature review complemented with a semi-structured interview. Findings Pharmaceutical DTCA showed a reduction in total spending, whereas the online channel experienced growth. DTCA affected the physician–patient relationship and patient satisfaction. Patients who received medication associated with DTCA showed higher satisfaction. DTCA of second-line drugs resulted in an increase of first-line drug utilization. Benefits of pharmaceutical DTCA include enhancing appropriate drug utilization and increasing awareness. DTCA might cause harm by interfering with physician’s decisions regarding drug choice. Research limitations/implications Limitations include limited available information of DTCA spending from pharmaceutical companies and lack of quantitative data on the effect of pharmaceutical DTCA. In addition, DTCA is sometimes affected by research bias. Practical implications Improvement in the physician–patient relationship and patient satisfaction, as well as in the quality of care provided may be demonstrated. Social implications Pharmaceutical firms using DTCA marketing advertisement methodologies can increase awareness of underdiagnosed conditions and affect medication costs and the utilization of appropriate drug utilization. Originality/value Review highlights current relationships between DTCA, patients, physicians and drug utilization to explore the effects DTCA on consumers.


2006 ◽  
Author(s):  
Luigi Anolli ◽  
Fabrizia Mantovani ◽  
Alessia Agliati ◽  
Olivia Realdon ◽  
Valentino Zurloni ◽  
...  

1987 ◽  
Vol 12 (1) ◽  
pp. 55-97 ◽  
Author(s):  
Fran Carnerie

AbstractMany individuals develop a temporary state of cognitive and emotional impairment after being diagnosed with catastrophic illness. Thus, when crucial decisions about medical treatment are required, they are unable to assimilate information; or worse, the legal need to be informed can rival a psychological desire to not be informed. The Canadian informed consent doctrine is unresponsive to crisis and clinically impracticable, and so paradoxically compromises the integrity and autonomy it was designed to protect. Many aspects of the physician-patient relationship and clinical setting also undermine the philosophical values enshrined in this doctrine. This further jeopardizes the individual's integrity. The Article explores proposals for change such as delaying the informing and consenting, improving the concept of consent, and improving the role of the physician.


2021 ◽  
pp. bmjspcare-2020-002764
Author(s):  
Catherine Owusuaa ◽  
Irene van Beelen ◽  
Agnes van der Heide ◽  
Carin C D van der Rijt

ObjectivesAccurate assessment that a patient is in the last phase of life is a prerequisite for timely initiation of palliative care in patients with a life-limiting disease, such as advanced cancer or advanced organ failure. Several palliative care quality standards recommend the surprise question (SQ) to identify those patients. Little is known about physicians’ views on identifying and disclosing the last phase of life of patients with different illness trajectories.MethodsData from two focus groups were analysed using thematic analysis with a phenomenological approach.ResultsFifteen medical specialists and general practitioners participated. Participants thought prediction of patients’ last phase of life, i.e. expected death within 1 year, is important. They seemed to find that prediction is more difficult in patients with advanced organ failure compared with cancer. The SQ was considered a useful prognostic tool; its use is facilitated by its simplicity but hampered by its subjective character. The medical specialist was considered mainly responsible for prognosticating and gradually disclosing the last phase. Participants’ reluctance to such disclosure was related to uncertainty around prognostication, concerns about depriving patients of hope, affecting the physician–patient relationship, or a lack of time or availability of palliative care services.ConclusionsPhysicians consider the assessment of patients’ last phase of life important and support use of the SQ in patients with different illness trajectories. However, barriers in disclosing expected death are prognostic uncertainty, possible deprivation of hope, physician–patient relationship, and lack of time or palliative care services. Future studies should examine patients’ preferences for those discussions.


Sign in / Sign up

Export Citation Format

Share Document